Western Wealth Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Western Wealth Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,070	Closed	-$478K	–	683
2024 Q1	$478K	Buy	12,070 +70	+0.6%	+$2.06K	0.04%	376
2023 Q4	$229K	Hold	12,000	–	–	0.02%	625
2023 Q3	$137K	Hold	12,000	–	–	0.01%	630
2023 Q2	$123K	Hold	12,000	–	–	0.01%	625
2023 Q1	$92.6K	Hold	12,000	–	–	0.01%	624
2022 Q4	$88.2K	Sell	12,000 -12,000	-50%	-$76.7K	0.01%	595
2022 Q3	$172K	Sell	24,000 -1,120	-4%	-$9.23K	0.01%	762
2022 Q2	$214K	Buy	+25,120	New	+$217K	0.01%	720
2022 Q1	–	Sell	-12,360	Closed	-$171K	–	852
2021 Q4	$171K	Buy	+12,360	New	+$153K	0.02%	584
2021 Q2	$108K	Buy	+12,000	New	+$130K	0.01%	615

Western Wealth Management's ALPN Position: Q2 2024 in Review

Western Wealth Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 12,070 shares — an estimated $478K sold.

Western Wealth Management first reported a position in ALPN in Q2 2021 and held it in 10 quarters. The position peaked at $478K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Western Wealth Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Western Wealth Management sold 12,070 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $478K.
Western Wealth Management first reported a position in Alpine Immune Sciences Inc in Q2 2021 and held it in 10 quarters.
Western Wealth Management's Alpine Immune Sciences Inc position peaked at $478K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Western Wealth Management's 13F filing for Q2 2024, filed 19 Jul 2024.